Indian Companies Commit $20.5 Billion in US Investments
Investment Summit Highlights
During an investment summit held in Maryland, Indian companies announced a historic commitment to invest $20.5 billion in the United States. A substantial portion of this funding, totaling over $19.1 billion, is earmarked for the pharmaceutical sector.
The U.S. embassy shared that the investments will extend across critical sectors including pharmaceuticals, advanced manufacturing, energy infrastructure, and emerging technologies. These initiatives are projected to generate thousands of jobs in both India and the U.S., while enhancing production capabilities and fostering collaborative innovation.
Ambassador Sergio Gor emphasized the importance of this investment, asserting a shared goal to double U.S.-India bilateral trade to $500 billion by the year 2030. He expressed pride in promoting fair, balanced, and mutually beneficial trade that is poised to attract significant international investments into the U.S. economy.
Focus on Pharmaceuticals
A significant share of the total investment is attributed to the Indian pharmaceutical industry, which is planning over $19.1 billion in manufacturing, research and development (R&D), and the establishment of new facilities in the U.S. Major players include Sun Pharmaceutical, which has announced an $11.75 billion acquisition of Organon & Co., based in New Jersey.
Other participating companies in the pharmaceutical sector comprise Aurobindo Pharma Ltd, Biocon Group, Cipla Ltd, Dr. Reddy’s Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Granules India Ltd, Jubilant Group, Lupin Ltd, Piramal Pharma Ltd, and Zydus Lifesciences Ltd. This financial commitment aims to strengthen U.S. healthcare supply chains, address essential medicine shortages, and enhance manufacturing and R&D capabilities.
Manufacturing Investments
Several Indian companies have also committed to substantial investments in the manufacturing sector. For instance, the JSW Steel company announced plans to invest $255 million to modernize its facilities located in Ohio and Texas.
The Abhyuday Group, based in Ahmedabad, will contribute over $900 million across five different sites in the U.S., which is expected to create approximately 1,500 jobs. Additionally, Jindal Pipe and Jindal Tubular USA from the PR Jindal Group will invest $87 million to expand operations in Texas and Mississippi, generating 140 new jobs.
Other notable investments include Jivo Wellness from Delhi, which will invest $15 million and create 50 direct jobs, as well as Polyhose Inc., investing $2 million in Los Angeles to bolster the shipbuilding industry.
Emerging Technologies and Infrastructure
Investment commitments from Indian companies in technology and digital infrastructure were also highlighted. Sterlite Technologies Ltd from Mumbai will invest $100 million, generating up to 500 jobs while supporting AI and telecommunications infrastructure development.
Additional technology firms include Techdome Solutions from Indore, with a planned investment of $7.5 million to create 100 jobs, and RoshAi from Kerala, investing $5 million in Texas, which will create 20 jobs. Other contributions include Atri AI and Kissflow, each investing $2 million in California and Houston respectively.
Energy and Research Development
Investment in the energy sector also features prominently in this initiative. MagnoInnovation Lab from Kerala will allocate $2 million to establish U.S. field operations aimed at supporting energy sector applications. Furthermore, the Indian Institute of Technology Madras Global Research Foundation will invest $4.5 million to create a research and collaboration hub in California, with plans for an additional site on the East Coast.
